• 83 Citations
  • 5 h-Index

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile


Dr Robin Gasiorowski completed medical training at Cambridge University and University College London, before moving to Australia in 2004. Following specialist haematology training at Royal Prince Alfred and Concord hospitals he now works as a clinical and laboratory haematologist, with appointments at Concord and Macquarie University Hospitals. He has a particular interest in acute leukaemia and high-grade lymphoma and in 2017 completed his PhD with the Dendritic Cell Research group at the University of Sydney, developing novel therapeutic antibodies for the treatment of Acute Myeloid Leukaemia (AML). Whilst he continues to be contribute to this group’s work, he also has a strong interest in clinical research, particularly in the development of novel immune therapies for patients with haematological malignancies. He has been a principal investigator on a number of industry and ALLG sponsored clinical trials for patients with high grade lymphoma and leukaemia.

Education/Academic qualification

Medicine, PhD, University of Sydney

MA (Cantab)




External positions

Senior Lecturer, University of Sydney

2015 → …

Staff Specialist in Haematology, Concord Repatriation General Hospital

2014 → …

Fingerprint Dive into the research topics where Robin Gasiorowski is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Outputs

  • 83 Citations
  • 5 h-Index
  • 8 Article
  • 7 Meeting abstract
  • 2 Review article

Examination of CD302 as a potential therapeutic target for acute myeloid leukemia

Lo, T. H., Abadir, E., Gasiorowski, R. E., Kabani, K., Ramesh, M., Orellana, D., Fromm, P. D., Kupresanin, F., Newman, E., Cunningham, I., Hart, D. N. J., Silveira, P. A. & Clark, G. J., 10 May 2019, In : PLoS ONE. 14, 5, p. 1-15 15 p., e0216368.

Research output: Contribution to journalArticle

Open Access
  • 7 Downloads (Pure)

    Outcomes of synchronous systemic and central nervous system (CNS) involvement of diffuse large B-cell lymphoma are dictated by the CNS disease: a collaborative study of the Australasian Lymphoma Alliance

    Wight, J. C., Yue, M., Keane, C., Johnston, A., Linton, K., Chin, C., Wai, S. H., Talaulikar, D., Gasiorowski, R., Yoon Cheah, C., Gregory, G. P., Dickinson, M., Minson, A., Coombes, C., Ku, M., Lam, S. & Hawkes, E. A., Oct 2019, In : British Journal of Haematology. 187, 2, p. 174-184 11 p.

    Research output: Contribution to journalArticle

  • A blood dendritic cell vaccine for acute myeloid leukemia expands anti-tumor T cell responses at remission

    Hsu, J. L., Bryant, C. E., Papadimitrious, M. S., Kong, B., Gasiorowski, R. E., Orellana, D., McGuire, H. M., Fazekas de St Groth, B., Joshua, D. E., Ho, P. J., Larsen, S., Iland, H. J., Gibson, J., Clark, G. J., Fromm, P. D. & Hart, D. N. J., 3 Apr 2018, In : OncoImmunology. 7, 4, p. 1-11 11 p., e1419114.

    Research output: Contribution to journalArticle

  • 8 Citations (Scopus)

    A blood dendritic cell vaccine for acute myeloid leukemia expands anti-tumour T cell responses at remission

    Fromm, P., Hsu, J., Bryant, C., Papadimitrious, M., Kong, B., Gasiorowski, R., Orellana, D., McGuire, H., de St Groth, B., Joshua, D., Ho, P. J., Larsen, S., Iland, H., Gibson, J., Clark, G. & Hart, D., 1 May 2018, In : European Journal of Immunology. 48, Suppl. 1, p. 74-75 2 p.

    Research output: Contribution to journalMeeting abstract

    Severe hemolysis and transfusion reactions after treatment with BGB-3111 and PD-1 antibody for Waldenström macroglobulinemia

    Othman, J., Verner, E., Tam, C. S., Huang, J., Lin, L., Hilger, J., Trotman, J. & Gasiorowski, R., 30 Apr 2018, In : Haematologica. 103, 5, p. e223-e225 3 p.

    Research output: Contribution to journalArticle